Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)
J. Clin. Oncol 2020 Jul 16;[EPub Ahead of Print], JJ Grob, R Gonzalez, N Basset-Seguin, O Vornicova, J Schachter, A Joshi, N Meyer, F Grange, JM Piulats, JR Bauman, P Zhang, B Gumuscu, RF Swaby, BGM HughesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.